Tech Company Financing Transactions
Cleara Biotech Funding Round
Cleara Biotech, operating out of Utrecht, secured $2.5 million in investment from Apollo Health Ventures, Curie Capital and Longevitytech.fund.
Transaction Overview
Company Name
Announced On
9/28/2022
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Seed
Investors
Proceeds Purpose
The proceeds will be used to progress the company's compounds toward clinical development and further build its developmental pipeline and management team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Yalelaan 62
Utrecht, 3584 CM
NL
Utrecht, 3584 CM
NL
Phone
Undisclosed
Website
Email Address
Overview
Cleara is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases through selective elimination of subtypes of cellular senescence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Marco Demaria
Co-Founder
Tobias Madl
Browse more venture capital transactions:
Prev: 9/28/2022: Rippl Care venture capital transaction
Next: 9/28/2022: Flora venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs